ALTO INGREDIENTS INC (ALTO) Fundamental Analysis & Valuation

NASDAQ:ALTOUS0215131063

Current stock price

4.16 USD
-0.36 (-7.96%)
At close:
4.23 USD
+0.07 (+1.68%)
After Hours:

This ALTO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALTO Profitability Analysis

1.1 Basic Checks

  • In the past year ALTO was profitable.
  • ALTO had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ALTO reported negative net income in multiple years.
  • In multiple years ALTO reported negative operating cash flow during the last 5 years.
ALTO Yearly Net Income VS EBIT VS OCF VS FCFALTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • The Return On Assets of ALTO (-13.24%) is worse than 80.72% of its industry peers.
  • The Return On Equity of ALTO (-23.13%) is worse than 73.49% of its industry peers.
Industry RankSector Rank
ROA -13.24%
ROE -23.13%
ROIC N/A
ROA(3y)-6.12%
ROA(5y)-3.64%
ROE(3y)-10.77%
ROE(5y)-6.69%
ROIC(3y)N/A
ROIC(5y)N/A
ALTO Yearly ROA, ROE, ROICALTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30 -40

1.3 Margins

  • ALTO's Operating Margin has declined in the last couple of years.
  • ALTO has a Gross Margin of 1.99%. This is amonst the worse of the industry: ALTO underperforms 90.36% of its industry peers.
  • ALTO's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALTO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.99%
OM growth 3YN/A
OM growth 5Y-18.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-8.4%
ALTO Yearly Profit, Operating, Gross MarginsALTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 -4 -6

5

2. ALTO Health Analysis

2.1 Basic Checks

  • ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALTO has more shares outstanding
  • The number of shares outstanding for ALTO has been increased compared to 5 years ago.
  • The debt/assets ratio for ALTO has been reduced compared to a year ago.
ALTO Yearly Shares OutstandingALTO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ALTO Yearly Total Debt VS Total AssetsALTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 0.91, we must say that ALTO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.91, ALTO is doing worse than 75.90% of the companies in the same industry.
  • A Debt/Equity ratio of 0.45 indicates that ALTO is not too dependend on debt financing.
  • ALTO's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. ALTO outperforms 67.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACCN/A
WACC9.01%
ALTO Yearly LT Debt VS Equity VS FCFALTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • ALTO has a Current Ratio of 3.56. This indicates that ALTO is financially healthy and has no problem in meeting its short term obligations.
  • ALTO's Current ratio of 3.56 is amongst the best of the industry. ALTO outperforms 89.16% of its industry peers.
  • A Quick Ratio of 2.30 indicates that ALTO has no problem at all paying its short term obligations.
  • ALTO's Quick ratio of 2.30 is amongst the best of the industry. ALTO outperforms 85.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 2.3
ALTO Yearly Current Assets VS Current LiabilitesALTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

6

3. ALTO Growth Analysis

3.1 Past

  • ALTO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.28%, which is quite impressive.
  • ALTO shows a decrease in Revenue. In the last year, the revenue decreased by -4.90%.
  • ALTO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.46% yearly.
EPS 1Y (TTM)119.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%149.12%
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y-11.75%
Revenue growth 5Y0.46%
Sales Q2Q%-1.85%

3.2 Future

  • ALTO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.58% yearly.
  • The Revenue is expected to grow by 20.86% on average over the next years. This is a very strong growth
EPS Next Y-128.69%
EPS Next 2Y53.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2Y20.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALTO Yearly Revenue VS EstimatesALTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ALTO Yearly EPS VS EstimatesALTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

1

4. ALTO Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.00 indicates a quite expensive valuation of ALTO.
  • The rest of the industry has a similar Price/Earnings ratio as ALTO.
  • When comparing the Price/Earnings ratio of ALTO to the average of the S&P500 Index (25.23), we can say ALTO is valued inline with the index average.
  • The Forward Price/Earnings Ratio is negative for ALTO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 26
Fwd PE N/A
ALTO Price Earnings VS Forward Price EarningsALTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALTO is valued a bit more expensive than the industry average as 78.31% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.47
ALTO Per share dataALTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALTO's earnings are expected to grow with 53.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.58%
EPS Next 3YN/A

0

5. ALTO Dividend Analysis

5.1 Amount

  • ALTO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALTO Fundamentals: All Metrics, Ratios and Statistics

ALTO INGREDIENTS INC

NASDAQ:ALTO (3/20/2026, 8:00:01 PM)

After market: 4.23 +0.07 (+1.68%)

4.16

-0.36 (-7.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners32.58%
Inst Owner Change35.41%
Ins Owners4.88%
Ins Owner Change0%
Market Cap321.73M
Revenue(TTM)917.93M
Net Income(TTM)-51.45M
Analysts82.5
Price Target4.34 (4.33%)
Short Float %1%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.02
Dividend Growth(5Y)-2.34%
DP-2.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)199.31%
Min EPS beat(2)-40.06%
Max EPS beat(2)438.68%
EPS beat(4)2
Avg EPS beat(4)8.57%
Min EPS beat(4)-385.93%
Max EPS beat(4)438.68%
EPS beat(8)3
Avg EPS beat(8)-45.05%
EPS beat(12)4
Avg EPS beat(12)-82.89%
EPS beat(16)6
Avg EPS beat(16)-778.96%
Revenue beat(2)1
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)4.09%
Revenue beat(8)3
Avg Revenue beat(8)-0.97%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)9
Avg Revenue beat(16)1.06%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 1.45
P/tB 1.5
EV/EBITDA 22.47
EPS(TTM)0.16
EY3.85%
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS11.93
BVpS2.88
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.22
Profitability
Industry RankSector Rank
ROA -13.24%
ROE -23.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.99%
FCFM N/A
ROA(3y)-6.12%
ROA(5y)-3.64%
ROE(3y)-10.77%
ROE(5y)-6.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-18.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-8.4%
F-Score3
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 5.41
Cap/Depr 15.44%
Cap/Sales 0.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 2.3
Altman-Z 0.91
F-Score3
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%149.12%
EPS Next Y-128.69%
EPS Next 2Y53.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y-11.75%
Revenue growth 5Y0.46%
Sales Q2Q%-1.85%
Revenue Next Year8.07%
Revenue Next 2Y20.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y71.7%
EBIT growth 3YN/A
EBIT growth 5Y-18.09%
EBIT Next Year1847.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-398.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-133.69%
OCF growth 3YN/A
OCF growth 5YN/A

ALTO INGREDIENTS INC / ALTO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALTO INGREDIENTS INC?

ChartMill assigns a fundamental rating of 3 / 10 to ALTO.


Can you provide the valuation status for ALTO INGREDIENTS INC?

ChartMill assigns a valuation rating of 1 / 10 to ALTO INGREDIENTS INC (ALTO). This can be considered as Overvalued.


What is the profitability of ALTO stock?

ALTO INGREDIENTS INC (ALTO) has a profitability rating of 1 / 10.


Can you provide the financial health for ALTO stock?

The financial health rating of ALTO INGREDIENTS INC (ALTO) is 5 / 10.


Is the dividend of ALTO INGREDIENTS INC sustainable?

The dividend rating of ALTO INGREDIENTS INC (ALTO) is 0 / 10 and the dividend payout ratio is -2.46%.